FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Entg Posts Mostly In-line Results And Guidance, Fills Cfo Role

作者

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

ENTG posted Q1 sales of $812M (+5% Y/Y), modestly ahead of consensus of $806M, driven by unit volume growth in advanced manufacturing processes. Non-GAAP EPS of $0.86 (+28% Y/Y) more materially beat Street expectations of $0.75, helped by continued expansion in adjusted gross margin (46.9%, +80 bps Y/Y) and adjusted operating margin of (23.6%, +150 bps). Q2 guidance called for sales and adjusted EPS midpoints of $830M and $0.80, respectively, near expectations for $828M/$0.77. We think ENTG's lower bar should mean minimal price movement despite somewhat underwhelming guidance, with semi equip peers being punished this earnings season for anything less than blowout results. We believe ENTG should continue facing headwinds in 2026 from mature node weakness in auto/industrial and competitive pressures in China, though we note recent signs of a stronger auto recovery in certain advanced areas. The company appointed Sukhi Nagesh as CFO effective May 18, 2026, bringing ~30 years of tech industry experience.

相关文章

Australia

Leerink Partners 将 Labcorp 的目标股价从 347 美元下调至 340 美元。

根据FactSet调查的分析师报告,Labcorp (LH) 的平均评级为“增持”,平均目标价为311.35美元。 (报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们:https://www..com/contact-us)Price: $257.19, Change: $+0.05, Percent Change: +0.02%

$LH
Australia

午盘涨幅最大的股票

临床阶段制药公司Avalyn Pharma (AVLN)周三晚间宣布,已将其规模扩大的首次公开募股(IPO)定价为每股18美元,发行约1670万股,目标募集资金约3亿美元。 该股在纳斯达克上市首日便大幅上涨,午后交易时段涨幅超过50%,达到约27.44美元,盘中成交量超过365万股。 Everspin Technologies (MRAM)周四宣布与一家美国主要承包商达成协议,将为美国国防工业基地客户提供Toggle MRAM工艺技术和工程服务。该协议价值4000万美元,有效期为两年半。 该股盘中成交量从日均约53.3万股飙升至超过1260万股,涨幅高达37%。 Viavi Solutions (VIAV) 股价上涨 15%,此前该公司公布的第三财季业绩和第四财季业绩指引均超出市场预期。 当日成交量超过 1510 万股,远高于日均约 587 万股的成交量。Price: $27.00, Change: $+9.00, Percent Change: +50.00%

$AVLN$MRAM$VIAV
Australia

Argus将纳斯达克目标股价从98美元上调至103美元。

根据FactSet调查的分析师数据,纳斯达克(NDAQ)的平均评级为“买入”,平均目标价为110.06美元。 (报道北美、亚洲和欧洲主要银行及研究机构的股票、商品和经济研究。研究机构可通过以下链接联系我们:https://www..com/contact-us)Price: $91.63, Change: $+0.36, Percent Change: +0.40%

$NDAQ